Rivaroxaban vs Apixaban and Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation

被引：0
|
作者：
Ray, Wayne A. [1 ]
Murray, Katherine T. [2 ]
机构：
[1] Vanderbilt Univ, Dept Hlth Policy, Sch Med, Nashville, TN USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 13期
关键词：
D O I：
10.1001/jama.2022.1425
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1290 / 1290
页数：1
相关论文
共 50 条
  • [1] Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation
    Ray, Wayne A.
    Chung, Cecilia P.
    Stein, C. Michael
    Smalley, Walter
    Zimmerman, Eli
    Dupont, William D.
    Hung, Adriana M.
    Daugherty, James R.
    Dickson, Alyson
    Murray, Katherine T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (23): : 2395 - 2404
  • [2] Apixaban vs rivaroxaban in patients with atrial fibrillation
    Reactions Weekly, 2020, 1796 (1) : 7 - 7
  • [3] Safety of apixaban and rivaroxaban in patients with atrial fibrillation on hemodialysis
    Ito, Hiroshi
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 154 - 155
  • [4] A Comparison of Bleeding Events Among Patients on Apixaban, Rivaroxaban, and Warfarin for Atrial Fibrillation and/or Venous Thromboembolism
    Schaefer, Jordan K.
    Errickson, Josh
    Kong, Xiaowen
    Ali, Mona A.
    Chipalkatti, Naina
    Haymart, Brian
    Kaatz, Scott
    Krol, Gregory D.
    Sood, Suman L.
    Froehlich, James
    Barnes, Geoffrey D.
    BLOOD, 2023, 142
  • [5] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [6] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
    Abdullah, Ahmad Salihin
    Tan, Hwee Pheng
    Mohd Saffian, Shamin
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
  • [7] Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation
    Rillig, Andreas
    Lin, Tina
    Plesman, Joaquina
    Heeger, Christian-H.
    Lemes, Christine
    Metzner, Andreas
    Mathew, Shibu
    Wissner, Erik
    Wohlmuth, Peter
    Ouyang, Feifan
    Kuck, Karl-Heinz
    Tilz, Roland Richard
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2016, 27 (02) : 147 - 153
  • [8] Outcomes of Apixaban Versus Rivaroxaban in Patients With Nonvalvular Atrial Fibrillation
    Jehle, D.
    Paul, K.
    Sorensen, B.
    ANNALS OF EMERGENCY MEDICINE, 2024, 84 (04) : S9 - S9
  • [9] Dabigatran, rivaroxaban and apixaban vs. high TTR warfarin in atrial fibrillation
    Sjalander, Sara
    Sjogren, Vilhelm
    Renlund, Henrik
    Norrving, Bo
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2018, 167 : 113 - 118
  • [10] Rivaroxaban and apixaban in patients with atrial fibrillation; a real-world data
    Aslan, Onur
    Yildirim, Sinan
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (04) : 948 - 957
12345